Trueblue, Inc. (TBI) is a publicly traded Industrials sector company. As of May 21, 2026, TBI trades at $5.44 with a market cap of $169.65M and a P/E ratio of -3.07. TBI moved +1.58% today. Year to date, TBI is +15.25%; over the trailing twelve months it is -3.55%. Its 52-week range spans $3.18 to $9.05. Analyst consensus is buy with an average price target of $5.50. Rallies surfaces TBI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
TBI financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. TBI recently traded at $5.44. Market cap is $169.65M. P/E ratio is -3.07. Revenue is $1.64B.
| Metric | Value |
|---|---|
| Price | $5.44 |
| Market Cap | $169.65M |
| P/E Ratio | -3.07 |
| EPS | $-1.79 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.05 |
| 52-Week Low | $3.18 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.64B |
| Net Income | $-53.41M |
| Gross Margin | 21.93% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $1.62B | $-47.96M | $-1.61 |
| 2024 | $1.57B | $-125.75M | $-4.17 |
| 2023 | $1.91B | $-14.17M | $-0.45 |
| 2022 | $2.25B | $62.27M | $1.89 |
1 analysts cover TBI: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.50.